All In Biotech

Drug Trial Radar · NCT07543224

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Apr 2026

Primary completion

Jan 2027

Study completion Dec 2027

Sponsor

Sponsor type
Industry
First posted
Apr 21, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase III Efficacy and Safety Study of RSS0393 Ointment in Plaque Psoriasis.

Conditions

  • Plaque Psoriasis Subjects

Interventions

  • RSS0393 ointment 0.03%Drug

    RSS0393 ointment 0.03%

  • RSS0393 ointment placeboDrug

    RSS0393 ointment placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Achieving a Physician's Global Assessment (PGA) response at Week 8Time frame: week8

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Peking Union Medical College Hospital (PUMCH)

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.